It’s safe to say that COVID-19, the country’s worst public #health crisis in a generation, was the single most important issue in the 2020 #Presidential race.
#HealthCare
The U.S. FDA announced today in a #Drug Safety Communication that it is requiring labeling changes for nonsteroidal anti-inflammatory drugs (NSAIDs).
#Medication #Healthcare
Federal agencies warned that cybercriminals are unleashing a wave of data-scrambling extortion attempts against the U.S. #healthcare system.
Some doctors prescribed blood thinners with anti-inflammatory drugs, raising the risk of haemorrhaging, the study says.
#Medications #Healthcare
If you’re enrolled in original #Medicare, you’ll need a Part D plan to cover your #prescription needs.
A new inhalation treatment for preventing the spread of COVID-19 is potentially far more effective than currently existing versions.
A majority of the U.S. remains susceptible to a coronavirus infection, Dr. Robert Redfield, director of the Centers for Disease Control and Prevention, told lawmakers Wednesday.
New prescriptions of the antimalarial drugs hydroxychloroquine and chloroquine shot up 80-fold year-over-year in March 2020.
President Donald Trump recently signed executive orders that he says will reduce drug prices by 50% “and even greater, in certain instances.”
Some veterans are across the country are making contingency plans in case they run out of medications before they arrive in the mail as U.S. Postal Service delays mount.